Fig. 1From: Lutetium-177-PSMA-I&T as metastases directed therapy in oligometastatic hormone sensitive prostate cancer, a randomized controlled trialA scheme of the trial with the randomization and study EOT stages. EOT = End of Treatment; PSMA = prostate specific membrane antigenBack to article page